A number of cell types have been used for cell transplantation studies in animal models to remyelinate demyelinated regions of the central nervous. These include committed myelin-forming cells such as oligodendrocytes and Schwann cells as well as precursor cells derived from either embryonic or adult brain. Recently cells within bone marrow have been shown to have the potential to differentiate into myelin-forming cells and to form myelin in animal models of demyelination upon direct injection into the lesion. We have recently shown that intravenous delivery of bone marrow cells can target a chemically-induced demyelination site in the rat spinal cord and remyelinate these axons. This opens the intriguing prospect of delivery of cells to systemically target sites of demyelination and to achieve myelin repair. The precise cell type within this fraction of bone marrow is not known, nor is the full repair potential of this approach understood. In this proposal we will study isolated bone marrow stromal cells (MSCs) to quantify remyelination induced by direct intraspinal and intravenous delivery of the MSCs to determine the extent to which we can repair a demyelinated lesion. These results will be compared to similar studies on injection of bone marrow mononuclear cells. We will use both anatomical and electrophysiological techniques to study the functional recovery of the remyelinated axons. We will also use a second lesion model system (a myelin-deficient mouse, shiverer) to determine if myelin repair by systemic bone marrow delivery can be achieved in a naturally occurring model of dysmyelination where gliosis is present. Many of the myelin profiles observed subsequent to bone marrow transplantation are characteristic of peripheral myelin. We will distinguish central from peripheral myelin. Completion of these studies should allow us to better understand the potential of MSCs to repair myelin. While these approaches are experimental in animal models, the prospect of using an expandable and renewable source of cells from bone marrow to repair the demyelinated CNS by systemic delivery has implications for future consideration of such an approach in man. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS043432-01A1
Application #
6575064
Study Section
Special Emphasis Panel (ZRG1-BDCN-2 (01))
Program Officer
Chiu, Arlene Y
Project Start
2002-12-01
Project End
2007-11-30
Budget Start
2002-12-01
Budget End
2003-11-30
Support Year
1
Fiscal Year
2003
Total Cost
$340,433
Indirect Cost
Name
Yale University
Department
Neurology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Honmou, Osamu; Houkin, Kiyohiro; Matsunaga, Takuya et al. (2011) Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134:1790-807
Sasaki, Masanori; Lankford, Karen L; Radtke, Christine et al. (2011) Remyelination after olfactory ensheathing cell transplantation into diverse demyelinating environments. Exp Neurol 229:88-98
Sasaki, Masanori; Honmou, Osamu; Radtke, Christine et al. (2011) Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells. PLoS One 6:e26577
Sasaki, Masanori; Lankford, Karen L; Brown, Robert J et al. (2010) Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor. Glia 58:1523-31
Zheng, Wei; Honmou, Osamu; Miyata, Kei et al. (2010) Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia. Brain Res 1310:8-16
Kirschner, Daniel A; Avila, Robin L; Gamez Sazo, Rodolfo E et al. (2010) Rapid assessment of internodal myelin integrity in central nervous system tissue. J Neurosci Res 88:712-21
Osaka, Misuzu; Honmou, Osamu; Murakami, Tomohiro et al. (2010) Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res 1343:226-35
Sasaki, Masanori; Honmou, Osamu; Kocsis, Jeffery D (2009) A rat middle cerebral artery occlusion model and intravenous cellular delivery. Methods Mol Biol 549:187-95
Markakis, Eleni A; Sasaki, Masanori; Lankford, Karen L et al. (2009) Convergence of cells from the progenitor fraction of adult olfactory bulb tissue to remyelinating glia in demyelinating spinal cord lesions. PLoS One 4:e7260
Toyama, Kentaro; Honmou, Osamu; Harada, Kuniaki et al. (2009) Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol 216:47-55

Showing the most recent 10 out of 35 publications